Trial Profile
Effects of valproate-semisodium and risperidone in children with autism.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2015
Price :
$35
*
At a glance
- Drugs Valproate semisodium (Primary) ; Risperidone
- Indications Autistic disorder
- Focus Therapeutic Use
- 07 Feb 2015 Primary endpoint 'Clinical Global Improvement' has not been met, according to an abstract presented at the 27th Annual Congress of the European College of Neuropsychopharmacology.
- 06 Feb 2015 New trial record